ActiGraph CentrePoint Insight Watch

ActiGraph CentrePoint Insight Watch is an FDA 510(k)-cleared medical device (K181077) manufactured by Actigraph. This device is classified under the Neurology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on May 23, 2018. Regulation: 8.